Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment
Hiroshi Kimura, Yok‐Lam Kwong
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

How we treat NK/T-cell lymphomas
Eric Tse, Weili Zhao, Jie Xiong, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 69
Forty Years of Molecular Diagnostics for Infectious Diseases
Jonathan E. Schmitz, Charles W. Stratton, David H. Persing, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 10
Open Access | Times Cited: 66
Clinical Spectrum of Epstein Barr Viremia in Hematological Disorders: Case Series and Review of Literature
Punit Jain, Kanika Khandelwal, Laxman Jessani, et al.
Indian Journal of Hematology and Blood Transfusion (2025)
Closed Access
Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
Benjamin Fournier, David Boutboul, Julie Bruneau, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 48
Quantification of low-level human cytomegalovirus and Epstein-Barr virus DNAemia by digital PCR
DeVon Hunter‐Schlichting, Rachel I. Vogel, Melissa A. Geller, et al.
Journal of Virological Methods (2024) Vol. 325, pp. 114876-114876
Closed Access | Times Cited: 5
Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 5
Delivery of microRNAs by Extracellular Vesicles in Viral Infections: Could the News be Packaged?
Fábio Seiti Yamada Yoshikawa, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 611-611
Open Access | Times Cited: 47
NK/T-cell lymphomas
Eric Tse, Yok‐Lam Kwong
Best Practice & Research Clinical Haematology (2019) Vol. 32, Iss. 3, pp. 253-261
Closed Access | Times Cited: 44
Extranodal NK/T cell lymphoma
Seong Hyun Jeong
Blood Research (2020) Vol. 55, Iss. S1, pp. S63-S71
Open Access | Times Cited: 36
Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
Mutaz Jamal Al-Khreisat, Nor Hayati Ismail, Abedelmalek Tabnjh, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2068-2068
Open Access | Times Cited: 10
Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
Charlotte Syrykh, Sarah Péricart, Claire Lamaison, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3315-3315
Open Access | Times Cited: 22
Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma
Antonella Farina, Edoardo Rosato, Michael York, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas
Eric Tse, Rex Au-Yeung, Yok‐Lam Kwong
Expert Review of Hematology (2019) Vol. 12, Iss. 11, pp. 927-935
Closed Access | Times Cited: 23
Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR− NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
Janice K. P. Lam, Tarik Azzi, Kwai Fung Hui, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 22
Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review
Zheng Yan, Shuna Yao, Yanyan Liu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 22
Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein–Barr Virus (EBV) Assessments—A Single Tertiary Referral Center Experience and Review of Literature
Eric Lau, Justin T. Moyers, Billy Chen Wang, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 899-899
Open Access | Times Cited: 18
Disparity analysis and prognostic value of pretreatment whole blood Epstein‐Barr virus DNA load and Epstein‐Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group
Ziyuan Shen, Lingling Hu, Mingkang Yao, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 2, pp. 327-334
Open Access | Times Cited: 18
Diagnostic Value of Whole-Blood and Plasma Samples in Epstein–Barr Virus Infections
Mateusz Rzepka, Dagmara Depka, Eugenia Gospodarek-Komkowska, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 476-476
Open Access | Times Cited: 6
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
Eric Tse, Christopher P. Fox, Alexander Glover, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 198-209
Open Access | Times Cited: 11
Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus–Positive T-Cell/Natural Killer Cell Lymphoproliferative Diseases
Jun‐ichi Kawada, Yasuko Kamiya, Akihisa Sawada, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 8, pp. 1307-1311
Closed Access | Times Cited: 17
Circulating cell‐free epstein–barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma
Amina Gihbid, Raja Benzeid, Abdellah Faouzi, et al.
Infectious Agents and Cancer (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 15
Epstein–Barr virus‐associated risk factors for post‐transplant lymphoproliferative disease in pediatric liver transplant recipients
Jesús Quintero, Javier Juampérez, María Mercadal‐Hally, et al.
Pediatric Transplantation (2022) Vol. 26, Iss. 6
Closed Access | Times Cited: 10
Diagnosis and monitoring of virus-associated cancer using cell-free DNA
Larissa LS Scholte, Jeffrey M. Bethony, Rena R. Xian
Current Opinion in Virology (2023) Vol. 60, pp. 101331-101331
Open Access | Times Cited: 5
The role of 18F-FDG PET/CT metabolic parameters in the differential diagnosis of post-transplant lymphoproliferative disorder after pediatric liver transplantation
Chaoran Wang, Guanyun Wang, Weimin Wang, et al.
Quantitative Imaging in Medicine and Surgery (2024) Vol. 14, Iss. 2, pp. 1323-1334
Open Access | Times Cited: 1
A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry
Jie Jin, Xia Mao, Donghua Zhang
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top